Chimeric Antigen Receptor (CAR) T-cell therapy is a groundbreaking approach in cancer immunotherapy and in autoimmune disease. In this application note, we detail the characterization and functionality assessment of CAR-T cells using both quantitative PCR (qPCR) and digital PCR (dPCR).
These advanced molecular techniques provide complementary insights, enhancing the quality control testing essential for ensuring the efficacy and safety of CAR-T cell therapies. Furthermore, we highlight the utility of our kits in streamlining the analysis process by facilitating efficient and accurate evaluation of CAR-T cell products.
Please fill out the short form below to download the application note: